42 results
Page 2 of 3
20-F/A
2qoaif9s5
23 Mar 15
Annual report (foreign) (amended)
12:00am
20-F/A
EX-4.38
0958dkt9
23 Mar 15
Annual report (foreign) (amended)
12:00am
424B5
0f0rrpzs0
6 Mar 15
Prospectus supplement for primary offering
12:00am
424B5
72t qs8le
5 Mar 15
Prospectus supplement for primary offering
12:00am
6-K
EX-1.1
89ao v9bzy9
7 Mar 14
BioLineRx Closes $24.1 Million Underwritten Public Offering
12:00am
424B5
o9dxs 9y13
4 Mar 14
Prospectus supplement for primary offering
12:00am
424B5
spg9chcb98972ybdi4d
3 Mar 14
Prospectus supplement for primary offering
12:00am
424B3
59r 68fklnqjt
8 Aug 13
Prospectus supplement
12:00am
424B5
0hlqcoyx2d 6y
6 Feb 13
Prospectus supplement for primary offering
12:00am
424B3
4m9yag8ray cqq
15 Oct 12
Prospectus supplement
12:00am
F-1
l50sylvmo
2 Oct 12
Registration statement (foreign)
12:00am
424B3
8wnq8m
28 Mar 12
Prospectus supplement
12:00am
20-F
h24dgqjc umk7c
22 Mar 12
Annual report (foreign)
12:00am
20FR12B/A
u970a2dnioru
15 Jul 11
Initial registration of securities (foreign private issuers) (amended)
12:00am
20FR12B
ik8ket6h
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.13
4rxjfuf69w5fqvs4
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.24
jn22t12 vuk7uteex
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am